Kenneth DenBleyker

406 total citations
11 papers, 343 citations indexed

About

Kenneth DenBleyker is a scholar working on Pharmacology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Kenneth DenBleyker has authored 11 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Kenneth DenBleyker's work include Cancer therapeutics and mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Kenneth DenBleyker is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Kenneth DenBleyker collaborates with scholars based in United States and Germany. Kenneth DenBleyker's co-authors include Joanne J. Bronson, J Fung-Tomc, John F. Barrett, Linda Discotto, Lawrence B. Snyder, Robert Mate, Michael J. Pucci, Yasutsugu Ueda, Michael J. Pucci and Hsu‐Tso Ho and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and European Journal of Medicinal Chemistry.

In The Last Decade

Kenneth DenBleyker

11 papers receiving 321 citations

Peers

Countries citing papers authored by Kenneth DenBleyker

Since Specialization

Citations

This map shows the geographic impact of Kenneth DenBleyker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth DenBleyker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth DenBleyker more than expected).

Fields of papers citing papers by Kenneth DenBleyker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth DenBleyker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth DenBleyker. The network helps show where Kenneth DenBleyker may publish in the future.

Co-authorship network of co-authors of Kenneth DenBleyker

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth DenBleyker. A scholar is included among the top collaborators of Kenneth DenBleyker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth DenBleyker. Kenneth DenBleyker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Antibacterial Pleuromutilin Derivatives based on Alternate Core Structures:Arigoni and Birch Chemistry Revisited 2008 ·Letters in Drug Design & Discovery ·Dane M. Springer, (unknown), (unknown), Joanne J. Bronson, Qi Gao, Stella Huang, Kenneth DenBleyker, Thomas J. Dougherty, J Fung-Tomc	4
2	Cyclopentanone ring-cleaved pleuromutilin derivatives 2006 ·European Journal of Medicinal Chemistry ·Dane M. Springer, Amy Bunker, (unknown), Margaret E. Sorenson, (unknown), Joanne J. Bronson, Kenneth DenBleyker, Thomas J. Dougherty, J Fung-Tomc	14
3	Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Kenneth DenBleyker, J Fung-Tomc, Hyekyung Yang, Junius M. Clark, (unknown), Joanne J. Bronson	40
4	Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials 2004 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence B. Snyder, Zhaoxing Meng, Robert Mate, Stanley V. D’Andrea, Anne Marinier, Claude Quesnelle, Patrice Gill, Kenneth DenBleyker, J Fung-Tomc, MaryBeth Frosco, Alain Martel, John F. Barrett, Joanne J. Bronson	33
5	Antimicrobial Evaluation of Nocathiacins, a Thiazole Peptide Class of Antibiotics 2004 ·Antimicrobial Agents and Chemotherapy ·Michael J. Pucci, Joanne J. Bronson, John F. Barrett, Kenneth DenBleyker, Linda Discotto, J Fung-Tomc, Yasutsugu Ueda	85
6	Discovery of the first antibacterial small molecule inhibitors of MurB 2003 ·Bioorganic & Medicinal Chemistry Letters ·Joanne J. Bronson, Kenneth DenBleyker, Paul Falk, Robert Mate, Hsu‐Tso Ho, Michael J. Pucci, Lawrence B. Snyder	76
7	Mechanism of Action of the Des-F(6) Quinolone BMS-284756 Measured by Supercoiling Inhibition and Cleavable Complex Assays 2001 ·Antimicrobial Agents and Chemotherapy ·Ping Wu, Laura Lawrence, Kenneth DenBleyker, John F. Barrett	5
8	Staphylococcus aureus Mutants Selected by BMS-284756 2001 ·Antimicrobial Agents and Chemotherapy ·Linda Discotto, Laura Lawrence, Kenneth DenBleyker, John F. Barrett	21
9	Selection and Genetic Characterization of Streptococcus pneumoniae Mutants Resistant to the Des-F(6) Quinolone BMS-284756 2001 ·Antimicrobial Agents and Chemotherapy ·(unknown), Kenneth DenBleyker, (unknown), Laura Lawrence, John F. Barrett, Thomas J. Dougherty	19
10	Antibacterial activities of cefprozil compared with those of 13 oral cephems and 3 macrolides 1995 ·Antimicrobial Agents and Chemotherapy ·J Fung-Tomc, E Huczko, Terry M. Stickle, Beatrice Minassian, B Kolek, Kenneth DenBleyker, D P Bonner, R E Kessler	36
11	Emergence of homogeneously methicillin-resistant Staphylococcus aureus 1991 ·Journal of Clinical Microbiology ·J Fung-Tomc, E Huczko, Elizabeth Gradelski, Kenneth DenBleyker, D P Bonner, R E Kessler	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact